Back to News
Market Impact: 0.1
Quantori Named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
Source: Business Wire
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Quantori was named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix Assessment 2026. The announcement provides no additional details on the assessment or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- South Korean carmaker Hyundai plans 'strategic' investment of $15.5 billion in India by 2032
- Applied Materials’ $5 billion AI lab aims to cut chip development time in half—and restore Silicon Valley’s edge
- China's exports likely grew by double-digits in September
- Meta’s Muse models reach the AI frontier—and kill any hopes to ‘pace’ it
- Singapore third-quarter GDP growth softens from four-year high but beats estimates
- FBI arrests OpenAI employee accused of planting secret recording device in conference room